Niche it!
BobbyGs Info

Barnes & Noble

Dipeptidyl peptidase-4 inhibitors

Drugs & Medication

Dipeptidyl peptidase-4 inhibitors

From Wikipedia the free encyclopedia, by MultiMedia

Back | Home | Up | Next


GLP-1 and DPP-4 inhibitors
GLP-1 and DPP-4 inhibitors

Dipeptidyl peptidase 4 inhibitors, also DPP-4 inhibitors, are a new class of oral hypoglycemics. Their mechanism of action is thought to result from increased GLP-1,[1][2] which inhibits glucagon release (which increases the blood glucose).

Drugs belonging to this class are vildagliptin and sitagliptin.

References

  1. ^ Behme MT, Dupre J, McDonald TJ. Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. BMC Endocr Disord. 2003 Apr 10;3(1):3. PMID 12697069. Full Free Text.
  2. ^ Dupre J, Behme MT, Hramiak IM, McFarlane P, Williamson MP, Zabel P, McDonald TJ. Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes. 1995 Jun;44(6):626-30. PMID 7789625.

External links


Home | Up | Diabetes mellitus | Alpha-glucosidase inhibitors | Dipeptidyl peptidase-4 inhibitors | Insulin therapies | Meglitinides | Sulfonylureas | Thiazolidinediones

Drugs & Medication, made by MultiMedia | Free content and software

This guide is licensed under the GNU Free Documentation License. It uses material from the Wikipedia.


Finish Line